autoimmune-diseases

Documents about autoimmune-diseases

• ICT Tools for the Diagnosis of Autoimmune Diseases#877439ClinicalTrials.gov
• Withdraw Drug in Stable IgG4-Related Disease#893233ClinicalTrials.gov
• Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis#863079ClinicalTrials.gov
• Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients#861687ClinicalTrials.gov
• Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions#847776ClinicalTrials.gov
• Fibromyalgia in systemic autoimmune rheumatic diseases: a mixed-methods study of patient and clinician perspectives.#262853NCBI PubMed Central
• Association between self-reported oral health issues and autoimmune diseases: evidence from UK biobank.#483455NCBI PubMed Central
• Trigger finger and the risk of systemic inflammatory and autoimmune rheumatic diseases: real-world evidence.#678548NCBI PubMed Central
• A Study of BEN301 Injection in the Treatment of Autoimmune Diseases#834221ClinicalTrials.gov
• Hypnosis in Internal Medecine#861230ClinicalTrials.gov
• Recurrence of autoimmune liver diseases after liver transplantation: exploratory analysis of a pooled Latin American cohort#469872Repositorio institucional EdocUR
• METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)#879456ClinicalTrials.gov
• Risk of Interstitial Lung Disease in COVID-19 Patients with Autoimmune Diseases Treated with Antiviral Agents#191545bioRxiv / medRxiv
• A comparative analysis of interstitial lung disease in the systemic autoimmune rheumatic diseases using All of Us data#308131Harvard DASH
• MCCs in adults with autoimmune and inflammatory rheumatic diseases: evidence to date and future directions.#406428NCBI PubMed Central
• Impact of dermatology targeted immunotherapies on autoimmune thyroid diseases: cytokine-network crosstalk and thyroid safety.#446219NCBI PubMed Central
• Adapting to living with systemic autoimmune rheumatic diseases; a qualitative exploration of patient and clinician perspectives#629597Goldsmiths Research Online
• To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement.#864105ClinicalTrials.gov
• Safety of Therapeutic Step-down in Neuromyelitis Optica#903334ClinicalTrials.gov
• Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis#915096ClinicalTrials.gov
• Causal inference for reliable biomarkers discovery with applications to cancer and autoimmune disease interactions#202424HAL (France)
• Characteristics of Patients With Thymoma in Chulalongkorn Hospital#834011ClinicalTrials.gov
• Clinical Study of CHT105 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases#846162ClinicalTrials.gov
• Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects#846703ClinicalTrials.gov
• Phase I Study of GSK2982772 in Japanese Healthy Male Participants#991994ClinicalTrials.gov
• Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions#887526ClinicalTrials.gov
• Spectre, caractéristiques, évolution et complications des maladies auto-immunes et inflammatoires systémiques en Martinique#274351HAL (France)
• A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia#861108ClinicalTrials.gov
• Autoimmune encephalitis in an underrepresented population : a case series from 2018 to 2023 in Bogotá, Colombia#341045Repositorio Institucional Javeriano
• ILD-SARDs Registry and Biorepository#870071ClinicalTrials.gov
• Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases#800193ClinicalTrials.gov
• Characterization of the Phenotypic Markers of B Cell Lymphocytes in Rheumatoid Arthritis#897953ClinicalTrials.gov
• Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)#881270ClinicalTrials.gov
• Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma#832097ClinicalTrials.gov
• Autoimmune Basis for Postural Tachycardia Syndrome#867963ClinicalTrials.gov
• A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus#910098ClinicalTrials.gov
• One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.#67686ClinicalTrials.gov
• Obesity as a Risk Factor for Autoimmune Diseases: A Systematic Review and Meta-Analysis#337740IRIS
• Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid#867600ClinicalTrials.gov
• Aetiology of TemporaL Arteritis Study#1009924ClinicalTrials.gov
• The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions#846935ClinicalTrials.gov
• Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes#979944ClinicalTrials.gov
• A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work#812759ClinicalTrials.gov
• CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy#827811ClinicalTrials.gov
• Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients#995361ClinicalTrials.gov
• Reproductive transitions and autoimmunity: implications for women's health in rheumatology and gastroenterology.#9963PubMed
• Staining patterns of autoantibodies in indirect immunofluorescence for autoimmune diseases of the digestive system: morphological characteristics and clinical significance.#415409NCBI PubMed Central
• “My world has shrunk”: a mixed-methods exploration of the impact of systemic autoimmune rheumatic diseases on patients’ lives#635080Goldsmiths Research Online
• Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers.#849177ClinicalTrials.gov
• Rituximab-induced hypogammaglobulinemia in autoimmune cytopenia and associated diseases.#922941HAL (France)